MetLife, Inc.

New York Stock Exchange
Back to all articles
Bullish +75

MetLife Q1 Earnings Call Highlights

AI-generated analysis

📈 MetLife reported Q1 adjusted earnings of $1.6 billion, or $2.42 per share, representing an 18% year-over-year increase.

💰 Adjusted return on equity reached 17%, which sits at the top end of the company's target range of 15% to 17%.

📉 The direct expense ratio improved to 11.9%, beating the 2026 annual target of 12.1%.

💸 Net income was $1.1 billion, or $1.74 per share, impacted by net investment losses from fixed maturity trading and private equity sales.

🤝 MetLife returned approximately $1.1 billion to shareholders via capital distributions and increased its dividend by 4.4%.

🏢 Group Benefits adjusted earnings rose 19% year-over-year to $439 million, driven by exceptional life mortality ratios of 80.1%.

📈 Retirement and Income Solutions earnings climbed 11% to $451 million, fueled by a total investment spread of 119 basis points.

🌏 International operations performed strongly with Asia earnings up 31%, Latin America up 5%, and EMEA rising 33%.

🇯🇵 Japan sales increased 26% on a constant currency basis, driven by foreign-exchange strength and new corporate accident products.

🇰🇷 Korea sales grew 44% thanks to dollar-denominated products and strength in won products amid rising equity markets.

📉 Latin America earnings declined 9% on a constant currency basis due to Mexico's VAT change and less favorable tax conditions.

⚠️ Middle East operations have not yet seen material impact, though management advises waiting for stabilization before assuming further effects.

💼 MetLife Investment Management reported $47 million in adjusted earnings following the full integration of the PineBridge acquisition.

🏥 Executives attributed part of the strong performance to favorable working-age mortality trends and light flu seasons.

💰 CFO John McCallion noted that persistency improved broadly across segments, particularly in dental products.

Bullish Signals
  • MetLife reported strong Q1 with adjusted earnings of $1.6 billion, representing an 18% year-over-year increase and an adjusted ROE of 17%.
  • The company returned approximately $1.1 billion to shareholders, increased its dividend by 4.4%, and maintained liquidity at the top of its target range.
  • Core businesses showed broad growth with Group Benefits earnings up 19% year-over-year and Retirement and Income Solutions earnings increasing 11%.
  • Adjusted premiums, fees, and other revenues rose 10% year-over-year, driven by strong performance in Asia (up 31%) and EMEA (up 33%).
  • Life mortality was exceptional with a Group Life mortality ratio of 80.1%, beating the company's target range.
  • Group Benefits sales increased 15%, while persistency improved broadly, particularly in dental, and voluntary product growth remained in double digits.
  • Asia sales increased 22% on a constant currency basis, with Japan sales rising 26% and Korea sales increasing 44%.
  • MetLife Investment Management adjusted earnings more than doubled to $47 million following its first fully integrated quarter post-PineBridge acquisition.
  • Executives highlighted broad-based growth across operating businesses, favorable underwriting trends, and disciplined capital management under the New Frontier strategy.
Risk Factors
  • The insurer reported net investment losses driven by normal trading activity within its fixed maturity portfolio and a modest loss tied to the sale of private equity limited partnership interests.
  • MetLife's core spread excluding variable investment income declined 4 basis points sequentially as the company rotated assets following large fourth-quarter pension risk transfer inflows.
  • Latin America adjusted earnings decreased 9% on a constant currency basis due to Mexico's value-added tax change and less favorable taxes, despite overall revenue growth.
  • Group Life mortality favorability could be driven by temporary factors like COVID-related pull-forward effects or the impact of GLP-1 drugs rather than sustainable underwriting trends.
  • Any mortality improvements that persist are expected to flow back into pricing gradually over years rather than quarters, potentially delaying immediate earnings benefits.
  • Asia growth in Japan was significantly boosted by a new corporate accident and health product launched during the quarter, raising questions about the sustainability of such one-time launches.
  • MetLife Investment Management reported adjusted earnings of $47 million following its first fully integrated quarter after the PineBridge acquisition, indicating limited historical data for comparison.
Full Analysis
MetLife Inc. (NYSE: MET) posted robust first-quarter earnings with adjusted profits reaching $1.6 billion, or $2.42 per share, marking an 18% increase year over year and beating expectations for all business segments. CEO Michel Khalaf attributed this performance to broad-based growth across operating units, favorable underwriting trends, and disciplined capital management under the New Frontier strategy. While net income was lower at $1.1 billion due to investment losses in fixed maturity portfolios, the company maintained liquidity near its target range and returned approximately $1.1 billion to shareholders through dividends and buybacks, increasing the dividend by 4.4%. The Group Benefits segment drove significant growth with adjusted earnings up 19% to $439 million, helped by exceptional life mortality trends driven by a light flu season and potential impacts from GLP-1 drugs. Retirement and Income Solutions also performed well, reporting adjusted earnings of $451 million as the company rotated assets linked to large pension risk transfer inflows, keeping its investment spread at 119 basis points. International operations showed strong momentum, particularly in Asia where earnings jumped 31% led by growth in Japan and Korea, while Latin America and EMEA regions delivered solid gains despite some tax headwinds in Mexico.